ZBH

#614
Zimmer Biomet Holdings, Inc. Common Stock
82.3 4 USD
-0.70%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
82.26
82.83
Intervallo Annuale
0.83
103.69
Variazione giornaliera
-0.70%
Variazione Mensile
+1.90%
Variazione di 6 mesi
-15.30%
Variazione Annuale
-20.44%
Chiusura Precedente
82.9 2
Open
82.7 4
Minimo
82.2 6
High
82.8 3
Volume
1 126
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
  • Market Capitalization 15.93 B
  • Employee 17 K
  • Founded N/A
  • CEO Ivan Tornos
  • Website www.zimmerbiomet.com
  • Headquarter Delaware, United States
  • FIGI BBG000BKPL53
  • Industry Dispositivi Medicali
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
23.42
Rapporto prezzo/fatturato
2.21
Dividendi per azione
0.24
Rendimento da dividendi %
1.86

Zimmer Biomet Holdings, Inc. Common Stock

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet. On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook.

Notizie